RPO LLC’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

RPO LLC’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-211,553	Closed	-$144K	–	222
2022 Q2	$144K	Hold	211,553	–	–	0.04%	122
2022 Q1	$334K	Buy	211,553 +126,109	+148%	+$182K	0.11%	114
2021 Q4	$204K	Buy	+85,444	New	+$259K	0.06%	119

Other funds holding CANO.WS

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

ICM

Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return

UFM

Ursa Fund Management Danville, California $108M AUM 30.27% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

Zazove Associates Incline Village, Nevada $1.22B AUM 1.91% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RPO LLC's CANO.WS Position: Q3 2022 in Review

RPO LLC sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q3 2022, closing a stake of 211,553 shares — an estimated $144K sold.

RPO LLC first reported a position in CANO.WS in Q4 2021 and held it in 3 quarters. The position peaked at $334K in Q1 2022. 30 funds tracked by Wall St. Rank hold CANO.WS as of Q3 2022.

RPO LLC reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q3 2022 after selling out during the quarter.
RPO LLC sold 211,553 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q3 2022, an estimated $144K.
RPO LLC first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q4 2021 and held it in 3 quarters.
RPO LLC's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $334K in Q1 2022.
30 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q3 2022.

Based on RPO LLC's 13F filing for Q3 2022, filed 10 Nov 2022.